The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women.
The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women.
复制标题
人工智能辅助细胞学诊断系统在大规模宫颈癌筛查中的应用:70万女性人群队列研究
DOI:
10.1002/cam4.3296
复制
发表时间:
2020-09
期刊:
影响因子:
4
通讯作者:
Wang L
中科院分区:
文献类型:
--
作者:
Bao H;Sun X;Zhang Y;Pang B;Li H;Zhou L;Wu F;Cao D;Wang J;Turic B;Wang L
Adequate cytology is limited by insufficient cytologists in a large‐scale cervical cancer screening. We aimed to develop an artificial intelligence (AI)‐assisted cytology system in cervical cancer screening program. We conducted a perspective cohort study within a population‐based cervical cancer screening program for 0.7 million women, using a validated AI‐assisted cytology system. For comparison, cytologists examined all slides classified by AI as abnormal and a randomly selected 10% of normal slides. Each woman with slides classified as abnormal by either AI‐assisted or manual reading was diagnosed by colposcopy and biopsy. The outcomes were histologically confirmed cervical intraepithelial neoplasia grade 2 or worse (CIN2+). Finally, we recruited 703 103 women, of whom 98 549 were independently screened by AI and manual reading. The overall agreement rate between AI and manual reading was 94.7% (95% confidential interval [CI], 94.5%‐94.8%), and kappa was 0.92 (0.91‐0.92). The detection rates of CIN2+ increased with the severity of cytology abnormality performed by both AI and manual reading (P trend < 0.001). General estimated equations showed that detection of CIN2+ among women with ASC‐H or HSIL by AI were significantly higher than corresponding groups classified by cytologists (for ASC‐H: odds ratio [OR] = 1.22, 95%CI 1.11‐1.34, P < .001; for HSIL: OR = 1.41, 1.28‐1.55, P < .001). AI‐assisted cytology was 5.8% (3.0%‐8.6%) more sensitive for detection of CIN2+ than manual reading with a slight reduction in specificity. AI‐assisted cytology system could exclude most of normal cytology, and improve sensitivity with clinically equivalent specificity for detection of CIN2+ compared with manual cytology reading. Overall, the results support AI‐based cytology system for the primary cervical cancer screening in large‐scale population. This study aims to assess the role of Artificial Intelligence (AI) in the detection of early cervical cancer in a low resource setting. Our results showed that AI‐assisted cytology could identify most of negative cytology, and showed higher positive predictive value for CIN2 or worse when compared with cytologists. This study indicates that AI‐assisted cytology could be very useful tool as a primary screening method in a large‐scale cervical cancer screening program to improve its effectiveness.
登录
查看更多内容
影响因子:
2.9
作者:
Sato M;Horie K;Hara A;Miyamoto Y;Kurihara K;Tomio K;Yokota H
通讯作者:
Yokota H
影响因子:
3.4
作者:
Renshaw, AA;Holladay, EB;Geils, KB
通讯作者:
Geils, KB
影响因子:
28.4
作者:
Cuzick, Jack;Myers, Orrin;Wheeler, Cosette M.
通讯作者:
Wheeler, Cosette M.
DOI:
10.1136/bmj.j504
发表时间:
2017-02-14
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Rozemeijer K;Naber SK;Penning C;Overbeek LI;Looman CW;de Kok IM;Matthijsse SM;Rebolj M;van Kemenade FJ;van Ballegooijen M
通讯作者:
van Ballegooijen M
影响因子:
3.7
作者:
Doornewaard, H;van den Tweel, J G;Jones, H W 3rd
通讯作者:
Jones, H W 3rd